(19)
(11) EP 2 152 754 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.07.2018 Bulletin 2018/27

(45) Mention of the grant of the patent:
25.04.2018 Bulletin 2018/17

(21) Application number: 08758782.0

(22) Date of filing: 27.05.2008
(51) International Patent Classification (IPC): 
C07K 16/30(2006.01)
A61P 35/00(2006.01)
 A61K 39/395(2006.01)
C12N 5/12(2006.01)
(86) International application number:
PCT/EP2008/004197
(87) International publication number:
WO 2008/145338 (04.12.2008 Gazette 2008/49)

(54)

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

MONOKLONALE ANTIKÖRPER GEGEN CLAUDIN-18 ZUR BEHANDLUNG VON KREBS

ANTICORPS MONOCLONAUX DIRIGÉS CONTRE LA CLAUDINE-18 POUR LE TRAITEMENT DU CANCER

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 29.05.2007 EP 07010622
29.05.2007 US 932099 P

(43) Date of publication of application:
17.02.2010 Bulletin 2010/07

(60) Divisional application:
18168460.6

(73) Proprietors:
  • Ganymed Pharmaceuticals GmbH
    55131 Mainz (DE)
  • TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
    55131 Mainz (DE)

(72) Inventors:
  • SAHIN, Ugur
    55116 Mainz (DE)
  • TÜRECI, Özlem
    55116 Mainz (DE)
  • BRANDENBURG, Gunda
    22880 Wedel (DE)
  • USENER, Dirk
    65193 Wiesbaden (DE)

(74) Representative: Schnappauf, Georg et al
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)


(56) References cited: : 
EP-A- 1 790 664
 WO-A-2004/047863
   
  • HEWITT KYLE J ET AL: "The claudin gene family: expression in normal and neoplastic tissues" BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 6, no. 1, 12 July 2006 (2006-07-12), page 186, XP021016181 ISSN: 1471-2407
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).